GreenPod Labs sells a small sachet, priced in rupees, that its own trials say keeps fruit and vegetables fresh 40 to 60 percent longer with no refrigeration at all. Yet the Chennai biotech that makes it booked operating revenue of just ₹98.4 lakh in the year to March 2025, as reported by Inc42 — a tiny number set against the problem it is chasing, because roughly 40 percent of India’s fruit and vegetables are lost before they reach a consumer, according to founder Deepak Rajmohan in an interview with Earth.Org.
That gap between the size of the problem and the size of the company is the whole story of GreenPod Labs. It is a nine-year-old, deep-science startup that has raised well under $2 million, employs a few dozen people, and is still measuring revenue in lakh rather than crore. It has also won a US$100,000 international biomimicry prize, pulled in India’s oldest angel network as a backer, and grown its top line almost fourfold in a single year. This deep dive works only from figures that trace to filings and reporting we opened while writing it; where the public record is thin — profit, valuation, exact headcount — we say so rather than guess.
Quick facts
| Company | GreenPod Labs Private Limited (CIN U01100TN2019PTC131954), Chennai, Tamil Nadu |
| Founded | Incorporated 9 October 2019 (Ministry of Corporate Affairs record via Tofler). Some trackers list 2023; the RoC incorporation date is 2019. |
| Founder(s) | Deepak Rajmohan (founder and CEO) and Vijay Anand, listed in filings as Deepak Kumar and Vijayanand Sakaram Rao |
| Businesses | Plant-extract sachets that extend the shelf life of fruit and vegetables at ambient temperature, sold to farmers, packhouses, distributors, retailers and e-commerce buyers |
| Latest FY revenue | ₹98.4 lakh in FY25 (year to 31 March 2025), up about 298 percent year on year (Inc42) |
| Latest FY profit/loss | Not disclosed in the sources reviewed; the company is early-stage and loss-making by its own accounts |
| Listed | Private |
| Market value / last valuation | Not publicly disclosed (marked undisclosed on CB Insights) |
| Key shareholders / CEO | Deepak Rajmohan (CEO); Indian Angel Network and Rockstart among institutional backers |
What they do
GreenPod Labs makes a crop-specific sachet that is dropped into a crate or carton of harvested produce. Inside the sachet are nano-encapsulated plant extracts that slowly release volatile compounds; these switch on the fruit’s own defence responses, slow the rate of ripening and suppress the microbes and fungi that cause rot. The company’s pitch is that this happens at ambient temperature, so a farmer or trader can buy extra shelf life without buying a cold room or a refrigerated truck.
- Core product: sachets of plant-derived actives that, per company trials reported by the NITI Aayog Frontier Tech portal and by Earth.Org, extend shelf life by 40 to 60 percent at ambient temperature.
- Mechanism: the sachet mimics how plants naturally resist stress, pests and fungal pathogens before harvest — a biomimicry approach, not a chemical coating or wax, so the company positions it as residue-free.
- Crops covered: mangoes, grapes, guavas, bananas, citrus and vegetables, each with its own formulation; the company had commercially launched three crop products and describes a roadmap of up to 12 crop-specific variants (Earth.Org, July 2025 reporting and NITI Aayog).
- Buyers: farmers, farmer producer organisations, packhouses, distributors, retailers and e-commerce grocery platforms (Entrackr, February 2022).
- Reach: more than 150 customers, per founder Deepak Rajmohan speaking to Earth.Org.
The origin
The founding insight came from a number Deepak Rajmohan could not unsee. Speaking to Earth.Org, he framed it plainly: in developing countries such as India, about 40 percent of all fruit and vegetables are lost before they reach the consumer, while in richer countries a similar share is wasted after purchase. Globally, he noted, roughly a third of food produced is lost in transport and storage, a loss he put at about $1.3 trillion and 8 percent of greenhouse-gas emissions. The problem, as he saw it, was not that Indian farmers grew too little; it was that too much of what they grew rotted on the way to a buyer.
Rajmohan had the training to do something about it. He studied agricultural engineering as an undergraduate, worked with smallholder farmers, and then took a master’s in food science at Oklahoma State University in the United States, where his projects included reducing by-products in the beer and wine industries. India’s structural disadvantage stuck with him: the average Indian farm is under two acres, against roughly 400 acres in the United States, which makes cold-chain economics brutal for the smallholder. Rather than try to build cold storage the country could not afford, he asked a different question — could the fruit be taught to defend itself for longer? He moved back to India and, with co-founder Vijay Anand, incorporated GreenPod Labs Private Limited in Chennai on 9 October 2019, according to the company’s Ministry of Corporate Affairs record.
The struggle years
GreenPod Labs is a hard-science company, and hard science is slow and expensive before it is anything else. The early years were spent in the lab, formulating actives for one crop at a time and running trials to prove the shelf-life claim held outside a controlled setting. The company incorporated in October 2019, months before the pandemic froze fieldwork, agricultural supply chains and fundraising across India — an unforgiving window for a startup whose product had to be tested in real packhouses and mandis, not on a laptop.
Money was tight in a way the funding headlines understate. The company’s paid-up capital was just ₹1.25 lakh against authorised capital of ₹20 lakh, per its filings on Tofler, and it did not close an institutional round until February 2022, more than two years after incorporation. Revenue stayed sub-crore for years: the RoC record shows operating revenue “under ₹1 crore” for the year to March 2023, and Inc42’s data has revenue at only ₹24.74 lakh in FY24. In other words, three-plus years in, GreenPod Labs was still selling less product in a year than a single mid-sized retailer moves in a day. The other quiet struggle is the one every crop-science company faces: a sachet tuned for mango is not a sachet for banana or grape, so each new crop meant a fresh round of formulation, trials and cost, stretching a small team and a small balance sheet across many small markets at once.
The turning point
The turn was not a single fundraise; it was proof that the science travelled — and then revenue that finally moved. In 2022 GreenPod Labs won the Biomimicry Institute’s Ray of Hope Prize, which carried US$100,000 in support, as reported by Earth.Org. For a company still measuring revenue in lakh, a six-figure dollar prize and an international stamp on the biomimicry claim mattered as much for credibility as for cash. Around the same window, the company ran field pilots that put real numbers on the pitch. According to the NITI Aayog Frontier Tech portal, a National Dairy Development Board pilot in Gujarat in 2022 cut spoilage by about 30 percent, a Kerala fish-transport pilot in 2023 added roughly two days of freshness, and mango growers in Tamil Nadu saw post-harvest losses fall by about 50 percent.
The clearest evidence of the turn is in the top line. Revenue went from ₹24.74 lakh in FY24 to ₹98.4 lakh in FY25 — an increase of about 298 percent in a single year, per Inc42. The base is small enough that the percentage flatters it, but the direction is unambiguous: after years of near-flat, sub-crore sales, the product started to sell. The company still books revenue under ₹1 crore, so this is a turning point measured against its own past, not against the market it wants — but it is the first year the numbers behaved like a business rather than a research project.
The money behind it
GreenPod Labs has raised modestly and mostly early-stage, with a mix of dilutive rounds, grants and a prize. The total raised is contested across trackers, so we give the range and name both sources.
- Pre-seed round: ₹4.05 crore (about $537,000, roughly €500,000 at the time), closed 15 February 2022, led by the Indian Angel Network with accelerator Rockstart as co-investor (Entrackr, February 2022; Rockstart newsroom; Entrepreneur India, which styled it a seed round).
- Ray of Hope Prize: US$100,000 in non-dilutive support from the Biomimicry Institute, 2022 (Earth.Org).
- Accelerator and grant rounds: an incubator/accelerator round via The Circulars (March 2023) and Conquest (November 2023), and a grant from ACT Grants dated 29 November 2024, per CB Insights.
- Latest round: about $324,000 dated 15 December 2025, led by Aarem Ventures, per Tracxn and Crunchbase.
- Total raised (contested): CB Insights records about $530,000 across 5 rounds, while Tracxn and Crunchbase put it at about $1.38 million across 7 rounds from 58 investors. The disclosed anchor in both is the February 2022 pre-seed.
- Valuation: not publicly disclosed by any source we opened.
How it makes money
The business model is straightforward physical-product economics wrapped around a patented formulation. GreenPod Labs manufactures sachets and sells them, priced per unit, into the fruit and vegetable supply chain; the margin sits in the chemistry, not the paper.
- Money in: sales of crop-specific sachets to farmers, FPOs, packhouses, distributors, retailers and e-commerce grocers (Entrackr, February 2022; Earth.Org).
- The value proposition it charges for: shelf-life extension of 40 to 60 percent without cold storage (company trials via NITI Aayog and Earth.Org), which lets a buyer cut spoilage without capital spend on refrigeration.
- Where the margin sits: in the proprietary plant-extract formulation and its encapsulation, not in the sachet itself — the defensible part is the science and the crop-by-crop recipes.
- Costs out: R&D and formulation for each new crop, field trials, and manufacturing — a structure that front-loads cost per crop before volume arrives.
- The part people get wrong: this is not a packaging-film business competing on price per metre; it is an actives business, so unit economics depend on how much spoilage the sachet prevents relative to its price, crop by crop. Published take rates or per-sachet pricing were not disclosed in the sources we opened, so we do not state a figure.
The numbers
The financial record is short and small, consistent with a deep-tech company still early in commercialisation. Precise operating revenue is available for FY24 and FY25; the FY23 figure is disclosed only as a band in the RoC record, and net profit or loss is not public in the sources reviewed.
| Fiscal year (₹ lakh) | Operating revenue | Net profit / loss |
| FY23 (to 31 Mar 2023) | Under ₹1 crore; exact figure not public (RoC via Tofler) | Not disclosed |
| FY24 (to 31 Mar 2024) | ₹24.74 lakh (Inc42) | Not disclosed |
| FY25 (to 31 Mar 2025) | ₹98.4 lakh (Inc42) | Not disclosed |
- FY25 revenue: ₹98.4 lakh, roughly 0.98 crore, up about 298 percent on FY24 (Inc42).
- FY24 revenue: ₹24.74 lakh; CB Insights records 2024 revenue of about $28,840, which is consistent with the rupee figure.
- FY23 revenue: “under ₹1 crore” operating revenue per the Ministry of Corporate Affairs record on Tofler, which also notes net worth fell 19.08 percent that year.
- Capital base: authorised capital ₹20 lakh, paid-up ₹1.25 lakh (Tofler).
- Headcount: reported as 36 employees by Inc42 and as 24 as of 31 August 2025 by The Company Check, so we quote the range of roughly two to three dozen staff rather than a single figure.
Where the money comes from
GreenPod Labs does not publish a formal segment or geography split, so the shape below is drawn from what the company and reporting have disclosed rather than from an audited breakdown.
- By crop: revenue is spread across a small number of commercially launched crop products — mango is the flagship, with grapes, guavas, bananas, citrus and vegetables in the mix (NITI Aayog; Earth.Org).
- By customer type: sales run across farmers, FPOs, packhouses, distributors, retailers and e-commerce grocers rather than one dominant channel (Entrackr).
- By geography: early traction and pilots are concentrated in India, with documented pilots in Tamil Nadu (mango), Gujarat (dairy, with NDDB) and Kerala (fish transport), per NITI Aayog. The founder has described ambitions to expand to other Asian and African markets (Earth.Org).
- The surprise: for a “packaging” startup, a meaningful slice of its early funding is non-dilutive — a US$100,000 international prize plus grant money from ACT Grants — reflecting how much of GreenPod Labs’ value in its first years came from validation and R&D support rather than product sales.
The risks
The risks here are the ordinary ones of a small, deep-science, single-technology company — concrete, not abstract.
- Scale risk: FY25 revenue of ₹98.4 lakh (Inc42) is tiny, and each new crop needs its own formulation and trials, so growth is gated by R&D throughput and cash, not just by demand. A small paid-up capital base of ₹1.25 lakh (Tofler) and total funding under $2 million leave little margin for error.
- Adoption and behaviour risk: the product only pays off if buyers change handling behaviour — dropping a sachet into every crate and trusting an ambient-temperature claim over the familiar habit of refrigeration. Convincing price-sensitive farmers and traders to pay per sachet for spoilage they cannot see in advance is a slow sell.
- Efficacy and evidence risk: the 40 to 60 percent shelf-life figures come largely from company trials reported via NITI Aayog and Earth.Org rather than independent audited studies; results vary by crop, ripeness, humidity and handling, and any high-profile field failure would be costly for a brand built on a single scientific promise.
- Concentration risk: with a handful of launched crops and pilots clustered in a few states, the company is exposed to seasonality and to the fortunes of specific crops such as mango.
The takeaway
The transferable lesson from GreenPod Labs is about the honest pace of deep tech. A startup can hold a genuinely novel, internationally recognised technology — biomimicry that wins a US$100,000 prize and pulls India’s oldest angel network into its cap table — and still, six years in, be turning over under ₹1 crore. That is not failure; it is the shape of building physical science for smallholder markets, where every crop is a new product, every claim needs a field trial, and cold, hard behaviour change stands between a good idea and a purchase order. The 298 percent revenue jump in FY25 matters precisely because it is the first sign the science has started to sell. For anyone building in agri-biotech or climate hardware, GreenPod Labs is a reminder to raise patiently, count grants and prizes as real runway, and judge progress against the slope of your own numbers rather than the size of the problem you are chasing.
Frequently asked questions
What does GreenPod Labs actually make?
It makes crop-specific sachets containing nano-encapsulated plant extracts. Dropped into a crate of harvested produce, they release compounds that trigger the fruit’s own defences, slowing ripening and suppressing rot, and, per company trials reported by NITI Aayog and Earth.Org, extend shelf life by 40 to 60 percent at ambient temperature without cold storage.
Who founded GreenPod Labs and when?
Deepak Rajmohan, who holds a master’s in food science from Oklahoma State University, co-founded the company with Vijay Anand. It was incorporated in Chennai on 9 October 2019, according to its Ministry of Corporate Affairs record, though some databases list a later founding year.
How much money has GreenPod Labs raised?
The total is contested: CB Insights records about $530,000 across five rounds, while Tracxn and Crunchbase report about $1.38 million across seven rounds from 58 investors. The disclosed anchor is a ₹4.05 crore (about $537,000) pre-seed round in February 2022 led by the Indian Angel Network with Rockstart co-investing. The company also won a US$100,000 Ray of Hope Prize in 2022.
What is GreenPod Labs’ revenue?
Operating revenue was ₹98.4 lakh in FY25 (year to 31 March 2025), up about 298 percent from ₹24.74 lakh in FY24, per Inc42. Revenue was “under ₹1 crore” in FY23 per the RoC record. Net profit or loss is not disclosed in the sources we reviewed.
Is GreenPod Labs profitable or listed?
It is a private company and, on the available public record, still early-stage and not profitable; no valuation or profit figure is publicly disclosed in the sources we opened.
Sources
Figures are as of September 2026. Currency converted at $1 ≈ ₹96.0 as of 18 September 2026 (Trading Economics).
- Entrackr — “IAN backs agri-biotech startup GreenPod Labs” (February 2022)
- Rockstart newsroom / FreshPlaza — GreenPod Labs raises €500K pre-seed (February 2022)
- Entrepreneur India — “GreenPod Labs Raises INR 4.05 Crore” (2022)
- Earth.Org — interview with Deepak Rajmohan on food loss (undated interview, accessed September 2026)
- NITI Aayog Frontier Tech portal — “Smart sachets extend fresh produce shelf life” (accessed September 2026)
- Inc42 — GreenPod Labs company profile: funding and revenue (2026)
- Tofler — GreenPod Labs Private Limited, Ministry of Corporate Affairs filings (CIN U01100TN2019PTC131954, accessed September 2026)
- The Company Check — GreenPod Labs Private Limited profile (accessed September 2026)
- CB Insights — GreenPod Labs financials and funding rounds (accessed September 2026)
- Tracxn and Crunchbase — GreenPod Labs funding and investors (2026)
Found an error? Write to us and we’ll correct it in the open, dated, on the piece.